Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
These two integrase inhibitors are associated with high blood sugar and diabetes.
Extended follow-up confirms that the long-acting monoclonal antibody works well for people with highly resistant HIV.
A clinical trial found no difference in outcomes based on whether participants switching to Cabenuva first took oral meds for four weeks.
Teva’s new version of TDF and emtricitabine doesn’t offer much of a price break, but that could come next spring.
The HIV Medicine Recycling Program urgently needs donations.
In 2019, almost 172 million prescription drugs were sent by mail. Since COVID-19, that number has increased nearly 21%.
At My House Clinic, which also offers hep C and COVID-19 services, PRIDE stands for “Promotes Respect Inclusion & Dignity for Everyone.”
Bob the Drag Queen hosts an educational entertainment event to tackle HIV issues.
The single-tablet regimen is now approved for previously treated people with an undetectable viral load.
With the help of a $6.2 million grant, researchers at Brown University hope to find out.
Mathematical models show that HIV gains in sub-Saharan Africa could be lost, say UNAIDS and WHO.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.